Donanemab has been described as a game-changer for Alzheimer's, with research showing it slowed its progressions by 35 per ...

Donanemab has been described as a game-changer for Alzheimer's, with research showing it slowed its progressions by 35 per ...

Updated clinical recommendations, including lifestyle changes, prevention strategies and treatment options, to reduce the risk of a first stroke have been outlined in a new guideline.

The idea that viral infections can play a role in at least some dementia cases goes back decades. It’s still controversial in the Alzheimer’s field, but as more researchers and funders have begun to ...

Neurophet, an artificial intelligence (AI) solution company for brain disease, hosted Neurophet Symposium with Professor ...

A new study published in the journal of Audiology Research found the intricate connections between hearing loss, central ...

A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients ...

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Health Canada has granted marketing authorization of DAYBUE™ (trofinetide) for the treatment of Rett syndrome in adult and pediatric ...

Alzamend Neuro, Inc. ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the ...